Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and imeglimin

moxifloxacin has been researched along with imeglimin in 1 studies

Compound Research Comparison

Studies
(moxifloxacin)		Trials
(moxifloxacin)		Recent Studies (post-2010)
(moxifloxacin)		Studies
(imeglimin)		Trials
(imeglimin)		Recent Studies (post-2010) (imeglimin)
3,1575521,690541652

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bolze, S; Dubourg, J; Felices, M; Fouqueray, P; Perrimond-Dauchy, S; Voiriot, P1

Trials

1 trial(s) available for moxifloxacin and imeglimin

ArticleYear
Absence of QTc prolongation in a thorough QT study with imeglimin, a first in class oral agent for type 2 diabetes mellitus.
    European journal of clinical pharmacology, 2020, Volume: 76, Issue:10

    Topics: Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Hypoglycemic Agents; Long QT Syndrome; Male; Moxifloxacin; Triazines

2020